AZE Share Price Performance
€0
-18.81 (-100.00%)
Price €0
Fair Value€13.20
Share Pricen/a
Azelis Group NV Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
AZE Community Narratives
AN
Fair Value €13.2 37.4% undervalued intrinsic discount
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
Fair Value €7.5 10.2% overvalued intrinsic discount
Specialty Chemicals Will Endure Market Headwinds With Gradual Relief
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value €24 65.6% undervalued intrinsic discount
Rising Demand For Specialty Chemicals Will Fuel Market Expansion
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
Key Takeaways Strategic acquisitions and a strong M&A pipeline suggest future revenue growth and expanded net margins from realized synergies. Investments in digitalization and sustainability could drive operational efficiencies, improving net margins and earnings stability long-term.Read more
147
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
€13.2
37.4% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
1.64% p.a.
Profit Margin
4.09%
Future PE
23.32x
Price in 2029
€17.39
Specialty Chemicals Will Endure Market Headwinds With Gradual Relief
Key Takeaways Reliance on end market recovery and successful acquisition integration introduces vulnerability to earnings growth, especially if life sciences momentum weakens or industrials underperform. Sustainability investments and ambitious ESG targets risk margin pressure, while higher working capital and limited order book visibility challenge cash flow and financial flexibility.Read more
30
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
€7.5
10.2% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
0.9% p.a.
Profit Margin
3.97%
Future PE
14.02x
Price in 2029
€9.92
Rising Demand For Specialty Chemicals Will Fuel Market Expansion
Key Takeaways Market consensus underestimates Azelis' rapid rebound in high-margin segments and strong post-acquisition integration, likely leading to outperformance in revenue and profit growth. Azelis' expanding role in value-added services, digitalization, and sustainability uniquely positions it for lasting market share gains and elevated customer retention.Read more
20
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
€24
65.6% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
7.38% p.a.
Profit Margin
5.53%
Future PE
26.11x
Price in 2028
€31
Trending Discussion
Recently Updated Narratives
AN
AZE: Margin Recovery Will Support Upside Despite Recent Discounted Reset
Fair Value: €13.2 37.4% undervalued intrinsic discount
9 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AZE: Downgrades And Sector Headwinds Will Pressure Premium P/E Expectations
Fair Value: €7.5 10.2% overvalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Demand For Specialty Chemicals Will Fuel Market Expansion
Fair Value: €24 65.6% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Azelis Group NV Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 30, 2026
- 0.46
- 23.03%
- 2.70%
- 63.0%
About AZE
- Founded
- 1996
- Employees
- 4000
- CEO
- WebsiteView website
Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.
